Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

A viral genome-wide association study (GWAS) was performed using RSV whole-genome sequencing to understand the relationship between prolonged RSV infection in infants and viral genotypes.

RSV is so contagious and so common that the CDC estimates virtually every child contracts it before they turn 2. While prior infection conveys some immunity, it gradually wanes, and people are ...

RSV is at its worst since 2012, according to Dr. Juanita Mora of the American Lung Association. “Usually 100% of kids will have had [RSV] by age 2. But over the last two years, ...

Viral genome sequencing demonstrated that multiple household infections within a 14-day period were likely caused by within-household ... Respiratory Syncytial Virus Infection in Adults; Viral ...

As the U.S. heads into colder weather months, when RSV cases tend to be higher, here's what you need to know about the virus including symptoms, treatments and vaccines.

Some hospitals in the U.S. are seeing an increase in RSV and higher levels of "walking pneumonia" among young children despite overall respiratory illness activity remaining low nationally.

Treatment therapies for adults with RSV have been elusive, but there are promising breakthroughs on the horizon. Join Drs Forest Arnold and Richard Plemper as they discuss.

Virtually all children get an RSV infection by the time they are 2, the CDC said. But the virus can cause complications in vulnerable populations, including infants, children under 2, people over ...

The first vaccines to guard against the respiratory illness RSV will soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots.. The ...

In a recent study published in Scientific Reports, researchers use immunoinformatics tools to computationally design a polyvalent multi-epitope vaccine against the respiratory syncytial virus (RSV ...